반응식
[C:1]([C:3]1[C:8]([NH:9][C:10]2[O:14][N:13]=[C:12]([C:15]3[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=3)[CH:11]=2)=[CH:7][C:6]([NH:21][C@@H:22]2[CH2:27][CH2:26][CH2:25][CH2:24][C@@H:23]2[NH:28]C(=O)OC(C)(C)C)=[C:5]([F:36])[CH:4]=1)#[N:2]>C(O)(C(F)(F)F)=O>[NH2:28][C@H:23]1[CH2:24][CH2:25][CH2:26][CH2:27][C@H:22]1[NH:21][C:6]1[C:5]([F:36])=[CH:4][C:3]([C:1]#[N:2])=[C:8]([NH:9][C:10]2[O:14][N:13]=[C:12]([C:15]3[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=3)[CH:11]=2)[CH:7]=1참가 물질
3
실험 절차
The compound tert-butyl (1S,2R)-2-(4-cyano-2-fluoro-5-(3-phenylisoxazol-5-ylamino)phenylamino)cyclohexylcarbamate (40 mg, 0.081 mmol) was dissolved in TFA (1.0 mL). After 20 min, TFA was removed in vacuo to give 4-((1R,2S)-2-aminocyclohexylamino)-5-fluoro-2-(3-phenylisoxazol-5-ylamino)benzonitrile (51 mg).
후처리
- customTFA was removed in vacuo
출처 및 근거
- ORD 기록
- ord-0620ba259f8c4a54b9d8fe226dc1559c
- 출처 데이터셋
- uspto-grants-2014_09
- 특허 번호
- US08846928B2
연결된 노트
불러오는 중…